{"filing":{"accession_number":"0001193125-26-252624","cik":"0000949858","ticker":"ACHV","company_name":"ACHIEVE LIFE SCIENCES, INC.","form":"8-K","filing_date":"2026-06-02","report_date":null,"primary_document":"achv-20260529.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/949858/000119312526252624/achv-20260529.htm"},"events":[{"id":7451,"run_id":6549,"accession_number":"0001193125-26-252624","anchor_item_number":"5.02","event_type":"exec_appointment","event_domain":"governance","is_material":true,"confidence":0.95,"summary":"The filing discloses the appointment of two new directors, Jeff Farrow and Reid Waldman, M.D., to the Board of Directors effective May 29, 2026, along with their committee assignments. While the section also mentions compensatory arrangements (stock options and retainers), the principal disclosed action is the appointment of these individuals to board roles, making exec_appointment the most salient classification. Board appointments are material to investors as they affect governance and oversight.","company_name":"ACHIEVE LIFE SCIENCES, INC.","ticker":"ACHV","filing_date":"2026-06-02","form":"8-K","submitted_at":null,"items":[{"id":3557,"accession_number":"0001193125-26-252624","item_number":"5.02","item_title":"Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.","event_type":"exec_appointment","event_domain":"governance","is_material":true,"confidence":0.95,"reasoning":"The filing discloses the appointment of two new directors, Jeff Farrow and Reid Waldman, M.D., to the Board of Directors effective May 29, 2026, along with their committee assignments. While the section also mentions compensatory arrangements (stock options and retainers), the principal disclosed action is the appointment of these individuals to board roles, making exec_appointment the most salient classification. Board appointments are material to investors as they affect governance and oversight.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-03T02:16:02.634375+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":3557,"accession_number":"0001193125-26-252624","item_number":"5.02","item_title":"Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.","event_type":"exec_appointment","event_domain":"governance","is_material":true,"confidence":0.95,"reasoning":"The filing discloses the appointment of two new directors, Jeff Farrow and Reid Waldman, M.D., to the Board of Directors effective May 29, 2026, along with their committee assignments. While the section also mentions compensatory arrangements (stock options and retainers), the principal disclosed action is the appointment of these individuals to board roles, making exec_appointment the most salient classification. Board appointments are material to investors as they affect governance and oversight.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-03T02:16:02.634375+00:00","company_name":"ACHIEVE LIFE SCIENCES, INC.","ticker":"ACHV","filing_date":"2026-06-02"}]}